Brief: Diamyd Medical Proceeds With Initiation Of Type 1 Diabetes Phase III Trial In Europe

Diamyd Medical AB

06/02/2022 17:19

Feb 6 (Reuters) - Diamyd Medical Ab  DMYDb.ST :
    * DIAMYD MEDICAL PROCEEDS WITH INITIATION OF TYPE 1 DIABETES
PHASE
III TRIAL IN EUROPE
    * DIAMYD MEDICAL - RESULTS FROM IN-DEPTH ANALYSES OF
MANUFACTURING
PROCESS HAVE SHOWN NO RISK ASSOCIATED WITH A PREVIOUSLY
SUSPECTED CONTAMINATION
    * FIRST PATIENTS ARE EXPECTED TO BE SCREENED IN MARCH

Source text for Eikon:  ID:nWkrdP5r 
Further company coverage:  DMYDb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))